Moderna’s sign is seen outside of their headquarters in Cambridge, MA on March 11, 2021.
Boston Globe | Getty Images
Moderna shares fell 8% on Thursday after it cut its Covid-19 vaccine sales forecast for the year to between $15 billion and $18 billion from $20 billion.
This is a developing story. Please check back for updates.
This article was originally published by Cnbc.com. Read the original article here.